Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: October 18, 2005
Last updated: January 21, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)